In any case, ours is the first report that age‐related increases in FGF21 are not associated with an impairment in the FGF21‐responsive machinery in adipose tissue and establish a distinction between alterations in the FGF21 endocrine system in aging and those in obesity and diabetes. The gene discussed is FGF21; the disease is diabetes mellitus.